Results of directly observed short-course chemotherapy in 112 842 Chinese patients with smear-positive tuberculosis

Lancet

Volumn 347, Issue 8998, 1996, Pages 358-362

  Murray, C J L ^a  

^a HARVARD CENTER FOR POPULATION AND DEVELOPMENT STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ETHAMBUTOL; ISONIAZID; ISONIAZID PLUS RIFAMPICIN; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ARTICLE; CHINESE; CLINICAL TRIAL; DRUG EFFICACY; FLUOROSCOPY; HUMAN; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SPUTUM ANALYSIS; TREATMENT FAILURE; TREATMENT OUTCOME; TUBERCULOSIS;

EID: 0030027949     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)90537-1     Document Type: Article

References (19)

1. Ministry of Public Health of the People's Republic of China. Nationwide random survey for the epidemiology of tuberculosis in 1990. Beijing: Ministry of Public Health, 1992.
2. Ministry of Public Health of the People's Republic of China. Nationwide Random Survey for the Epidemiology of Tuberculosis in 1984/1985. Beijing: Ministry of Public Health, 1988.
3. Ministry of Public Health and the People's Republic of China. Nationwide random survey for the epidemiology of tuberculosis in 1979. Beijing: Ministry of Public Health, 1981.
4. Murray CJL, Lopez AD. Global and regional cause of death patterns in 1990. Bull WHO 1994; 72: 447-80.
5. WHO. Tuberculosis programme. Framework for effective tuberculosis control. WHO/TB/94.17.
6. Ministry of Public Health of the People's Republic of China. Tuberculosis programme in China. Fifth meeting of WHO CARG, Oslo, 1995. WHO/GTB/CARG/95.9.
7. Broekmans JF. Control strategies and programme management. In: Porter JDH, McAdam KPWJ. Tuberculosis: back to the future. Chichester: John Wiley and Sons, 1994: 171-92.
8. National Tuberculosis Institute (Bangalore). Annual Report 1989. Bangalore: National Tuberculosis Institute, 1990.
9. Bloom B, Murray CJL. Tuberculosis: commentary on a reemergent killer. Science 1992; 257: 1055-64.
10. Bell J, Yach D. Tuberculosis compliance in the western Cape, 1984. S Afr Med J 1988; 73: 31-33.
11. Cheung R, Dickins J, Nicholson PW, et al. Compliance with antituberculosis therapy: a field trial of a pill-box with a concealed electronic recording device. Eur J Clin Pharm 1988; 35: 401-07.
12. Farmer P, Robin S, Ramilus SL, Kim JY. Tuberculosis, poverty, and "compliance": lessons from rural Haiti. Semin Respir Infect 1991; 6: 254-60.
13. Manolo F, Tan F, Sbarbaro HA, Iseman MD. Community-based short-course treatment of pulmonary tuberculosis in a developing nation. Am Rev Respir Dis 1990; 142: 1301-05.
14. Miles SH, Maat RB. A successful supervised outpatient short-course tuberculosis treatment program in an open refugee camp on the Thai-Cambodian border. Am Rev Respir Dis 1984; 130: 827-30.
15. Morisky DE, Malotte CK, Choi P, Davidson P, Rigler D, Sugland B, Langer M. A patient education program to improve adherence rates with antituberculosis drug regimens. Health Educ Q 1990; 17: 253-67.
16. Valeza FS, McDougall AC. Blister calendar packs for treatment of tuberculosis. Lancet 1990; 335: 473.
17. Wilkinson D. High compliance tuberculosis treatment programme in a rural community. Lancet 1994; 343: 647-48.
18. Murray CJL, Styblo K, Rouillon A. Tuberculosis in developing countries: burden intervention and cost. Bull IUATLD 1990; 65: 2-20.
19. Murray CJL, DeJonghe E, Chum HJ, Nyangulu DS, Salomao A, Styblo K. Cost-effectiveness of chemotherapy for pulmonary tuberculosis in three sub-Saharan African countries. Lancet 1991; 338: 1305-08.